ES2148967T3 - Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia. - Google Patents

Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.

Info

Publication number
ES2148967T3
ES2148967T3 ES97919169T ES97919169T ES2148967T3 ES 2148967 T3 ES2148967 T3 ES 2148967T3 ES 97919169 T ES97919169 T ES 97919169T ES 97919169 T ES97919169 T ES 97919169T ES 2148967 T3 ES2148967 T3 ES 2148967T3
Authority
ES
Spain
Prior art keywords
treatment
diagnosis
eclampsy
substances
eclampsia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919169T
Other languages
English (en)
Inventor
Thomas William Rademacher
Patricia Mclean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rademacher Group Ltd
Original Assignee
Rademacher Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rademacher Group Ltd filed Critical Rademacher Group Ltd
Application granted granted Critical
Publication of ES2148967T3 publication Critical patent/ES2148967T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNAS SUSTANCIAS Y UNOS PROCEDIMIENTOS DESTINADOS AL DIAGNOSTICO Y TRATAMIENTO DE LA PREECLAMPSIA Y DE LA DIABETES. SE REFIERE EN ESPECIAL AL PAPEL DE LOS FOSFOGLICANOS DE INOSITOL DE TIPO P (DE LOS IPG) EN LA APARICION DE LA PREECLAMPSIA. EL OBJETIVO DE ESTA INVENCION CONSISTE EN PROCEDIMIENTOS DE DIAGNOSTICO DE LA PREECLAMPSIA QUE PERMITEN LA DETERMINACION DEL NIVEL DE LOS IPG DE TIPO P Y UTILIZAR LOS ANTAGONISTAS DE LOS IPG DE TIPO P PARA EL TRATAMIENTO DE LA PREECLAMPSIA, ASI COMO UN PROCEDIMIENTO DE CRIBADO DE LOS ANTAGONISTAS DE LOS IPG DE TIPO P PARA EL TRATAMIENTO DE LA PREECLAMPSIA, ASI COMO UN PROCEDIMIENTO DE CRIBADO DE LOS ANTAGONISTAS DE LOS IPG DE TIPO P.
ES97919169T 1996-09-11 1997-09-11 Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia. Expired - Lifetime ES2148967T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9618931.1A GB9618931D0 (en) 1996-09-11 1996-09-11 Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes

Publications (1)

Publication Number Publication Date
ES2148967T3 true ES2148967T3 (es) 2000-10-16

Family

ID=10799739

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919169T Expired - Lifetime ES2148967T3 (es) 1996-09-11 1997-09-11 Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.

Country Status (14)

Country Link
US (2) US6495330B1 (es)
EP (1) EP0939651B1 (es)
JP (1) JP4457191B2 (es)
CN (1) CN1146445C (es)
AT (1) ATE193452T1 (es)
AU (1) AU715884B2 (es)
BR (1) BR9711752A (es)
CA (1) CA2264939C (es)
DE (1) DE69702209T2 (es)
DK (1) DK0939651T3 (es)
ES (1) ES2148967T3 (es)
GB (1) GB9618931D0 (es)
IL (1) IL128893A0 (es)
WO (1) WO1998010791A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
GB9801899D0 (en) * 1998-01-29 1998-03-25 Univ London Neurotrophic properties of ipgs analogues
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies
CA2321113A1 (en) * 1998-03-18 1999-09-23 Thomas William Rademacher Anti-inositolphosphoglycan monoclonal antibodies
GB9806645D0 (en) * 1998-03-27 1998-05-27 Univ London Materials and methods relating to the treatment of conditions involving mast cells,basophils and eosinophils
GB9828564D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Materials and methods for the treatment and diagnosis of cancer
GB9914326D0 (en) * 1999-06-18 1999-08-18 Rademacher Group Limited Materials and methods relating to the diagnosis and treatment of pre-eclampsia
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
ATE390434T1 (de) * 2000-05-12 2008-04-15 Rodaris Pharmaceuticals Ltd Inositolphosphoglycanderivate und ihre medizinische verwendung
AU778672B2 (en) * 2000-05-12 2004-12-16 Sr Pharma Plc Assays
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
WO2001085746A1 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
GB0015625D0 (en) * 2000-06-26 2000-08-16 Univ London Materials and methods relating for the treatment and diagnosis of pre-eclampsia
CA2515012A1 (en) * 2003-02-04 2004-08-26 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
SG155257A1 (en) * 2004-09-24 2009-09-30 Beth Israel Hospital Methods of diagnosing and treating complications of pregnancy
US20120101021A1 (en) 2009-02-06 2012-04-26 Surendra Sharma Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
PL3758739T3 (pl) * 2018-02-28 2024-09-16 Pharming Intellectual Property B.V. Leczenie i zapobieganie stanowi przedrzucawkowemu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032112T2 (de) * 1989-08-03 1998-07-09 Univ California Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies

Also Published As

Publication number Publication date
CN1146445C (zh) 2004-04-21
US20030091581A1 (en) 2003-05-15
AU4310297A (en) 1998-04-02
JP4457191B2 (ja) 2010-04-28
IL128893A0 (en) 2000-01-31
BR9711752A (pt) 2000-01-18
ATE193452T1 (de) 2000-06-15
CA2264939C (en) 2012-06-05
EP0939651B1 (en) 2000-05-31
GB9618931D0 (en) 1996-10-23
US6495330B1 (en) 2002-12-17
EP0939651A1 (en) 1999-09-08
DE69702209T2 (de) 2000-11-09
AU715884B2 (en) 2000-02-10
DE69702209D1 (de) 2000-07-06
DK0939651T3 (da) 2000-09-04
CN1235556A (zh) 1999-11-17
CA2264939A1 (en) 1998-03-19
JP2001501598A (ja) 2001-02-06
WO1998010791A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
WO2000001845A3 (de) Verfahren zur frühen diagnose von carcinomen
MX9803253A (es) Metodo para el tratamiento de colitis establecida utilizando anticuerpos contra il-12.
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
WO2000008464A3 (de) Verfahren zur bestimmung der immunabwehr des blutes sowie testkit hierfür
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
SE9604815D0 (sv) A metod of diagnosis
DE58903401D1 (de) Cyclohexenonoximether, verfahren zu ihrer herstellung und ihre verwendung als herbizid.
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
EP1163515A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR DISEASES WITH DISTURBED GLUCOSE TOLERENCE
WO1998018430A3 (en) P2y receptor antagonists
GR3029483T3 (en) Antibodies against t-cells as therapeutics
DE68921374D1 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
DE69623280D1 (de) Inhibierung der amulin-freisetzung
EP1019092A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR DISEASES WITH DISTURBED GLUCOSE TOLERANCE
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
CA2243372A1 (en) Methods of diagnosing muscle damage
WO1997041443A3 (en) Method for screening compounds
DE69532611D1 (de) Mittel zur behandlung von autoimmunkrankheiten
IL141858A0 (en) Diagnostic method for detecting disturbances of the pancreas
AU2685699A (en) Methods of screening compounds for bioactivity in organized tissue
ES2175842T3 (es) Antagonistas de kv2.1.
DE69004273D1 (de) Vorrichtung zum Befestigen von Frästrommeln an einem Baggergerät,das für das Ausheben von Gräben im Boden bestimmt ist.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 939651

Country of ref document: ES